The Filings Report

Lam Research

LRCXNasdaqCIK 707549Technology / Semiconductor Equipmentfiscal year ends June69 quarters since 2009

Revenue, Q1 FY2027
$8.2B
+54.4% on Q1 FY2026
Net income
$2.8B
+75.5% on Q1 FY2026
Free cash flow
$3.2B
+103.3% on Q1 FY2026
Diluted EPS
$2.19
+76.6% on Q1 FY2026
Revenue, TTM
$26.1B
trailing four quarters
Net margin, TTM
32.3%
net income $8.4B
Free cash flow, TTM
$6.5B
$7.6B less $1.0B capex
Cash and equivalents
$7.4B
long-term debt —, Sep 27, 2026
Shares, 12-month change
−0.6%
1.25B shares, Sep 27, 2026
Buybacks, TTM
$3.9B
1.3% of market value
Dividends, TTM
$1.3B
0.4% of market value
Market value
$298.7B
at the close, buybacks

Latest quarter Q1 FY2027, filed October 22, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.

In Q1 FY2027, the quarter ended September 27, 2026, Lam Research reported revenue of $8.2B, +54.4% on Q1 FY2026, and net income of $2.8B (+75.5%). Operating margin was 40.0%. Free cash flow, operating cash flow less capital expenditures, was $3.2B ($3.5B less $258M). Diluted earnings per share were $2.19.

The last 16 quarters

Q2 FY2023 to Q1 FY2027, through the filing of October 22, 2026.

Revenue and net incomeRevenueNet income
$0$3B$5B$8B$10BQ2'23, Revenue: $5.3BQ2'23, Net income: $1.5BQ2'23Q3'23, Revenue: $3.9BQ3'23, Net income: $814MQ3'23Q4'23, Revenue: $3.2BQ4'23, Net income: $803MQ4'23Q1'24, Revenue: $3.5BQ1'24, Net income: $887MQ1'24Q2'24, Revenue: $3.8BQ2'24, Net income: $954MQ2'24Q3'24, Revenue: $3.8BQ3'24, Net income: $966MQ3'24Q4'24, Revenue: $3.9BQ4'24, Net income: $1.0BQ4'24Q1'25, Revenue: $4.2BQ1'25, Net income: $1.1BQ1'25Q2'25, Revenue: $4.4BQ2'25, Net income: $1.2BQ2'25Q3'25, Revenue: $4.7BQ3'25, Net income: $1.3BQ3'25Q4'25, Revenue: $5.2BQ4'25, Net income: $1.7BQ4'25Q1'26, Revenue: $5.3BQ1'26, Net income: $1.6BQ1'26Q2'26, Revenue: $5.3BQ2'26, Net income: $1.6BQ2'26Q3'26, Revenue: $5.8BQ3'26, Net income: $1.8BQ3'26Q4'26, Revenue: $6.7BQ4'26, Net income: $2.3BQ4'26Q1'27, Revenue: $8.2BQ1'27, Net income: $2.8BQ1'27$0$3B$5B$8B$10BQ2'23, Revenue: $5.3BQ2'23, Net income: $1.5BQ3'23, Revenue: $3.9BQ3'23, Net income: $814MQ3'23Q4'23, Revenue: $3.2BQ4'23, Net income: $803MQ1'24, Revenue: $3.5BQ1'24, Net income: $887MQ1'24Q2'24, Revenue: $3.8BQ2'24, Net income: $954MQ3'24, Revenue: $3.8BQ3'24, Net income: $966MQ3'24Q4'24, Revenue: $3.9BQ4'24, Net income: $1.0BQ1'25, Revenue: $4.2BQ1'25, Net income: $1.1BQ1'25Q2'25, Revenue: $4.4BQ2'25, Net income: $1.2BQ3'25, Revenue: $4.7BQ3'25, Net income: $1.3BQ3'25Q4'25, Revenue: $5.2BQ4'25, Net income: $1.7BQ1'26, Revenue: $5.3BQ1'26, Net income: $1.6BQ1'26Q2'26, Revenue: $5.3BQ2'26, Net income: $1.6BQ3'26, Revenue: $5.8BQ3'26, Net income: $1.8BQ3'26Q4'26, Revenue: $6.7BQ4'26, Net income: $2.3BQ1'27, Revenue: $8.2BQ1'27, Net income: $2.8BQ1'27

Net income losses drawn in red.

Free cash flow
$0$1B$2B$3B$4BQ2'23, Free cash flow: $977MQ2'23Q3'23, Free cash flow: $1.6BQ3'23Q4'23, Free cash flow: $1.0BQ4'23Q1'24, Free cash flow: $874MQ1'24Q2'24, Free cash flow: $1.3BQ2'24Q3'24, Free cash flow: $1.3BQ3'24Q4'24, Free cash flow: $762MQ4'24Q1'25, Free cash flow: $1.5BQ1'25Q2'25, Free cash flow: $554MQ2'25Q3'25, Free cash flow: $1.0BQ3'25Q4'25, Free cash flow: $2.4BQ4'25Q1'26, Free cash flow: $1.6BQ1'26Q2'26, Free cash flow: $1.2BQ2'26Q3'26, Free cash flow: $810MQ3'26Q4'26, Free cash flow: $1.3BQ4'26Q1'27, Free cash flow: $3.2BQ1'27$0$1B$2B$3B$4BQ2'23, Free cash flow: $977MQ3'23, Free cash flow: $1.6BQ3'23Q4'23, Free cash flow: $1.0BQ1'24, Free cash flow: $874MQ1'24Q2'24, Free cash flow: $1.3BQ3'24, Free cash flow: $1.3BQ3'24Q4'24, Free cash flow: $762MQ1'25, Free cash flow: $1.5BQ1'25Q2'25, Free cash flow: $554MQ3'25, Free cash flow: $1.0BQ3'25Q4'25, Free cash flow: $2.4BQ1'26, Free cash flow: $1.6BQ1'26Q2'26, Free cash flow: $1.2BQ3'26, Free cash flow: $810MQ3'26Q4'26, Free cash flow: $1.3BQ1'27, Free cash flow: $3.2BQ1'27

Operating cash flow less capital expenditures; negative quarters in red.

Cash and equivalents against long-term debtCash and equivalentsLong-term debt
$0$2B$4B$6B$8BQ2'23, Cash and equivalents: $4.5BQ2'23Q3'23, Cash and equivalents: $5.3BQ3'23Q4'23, Cash and equivalents: $5.3BQ4'23, Long-term debt: $5.0BQ4'23Q1'24, Cash and equivalents: $5.1BQ1'24Q2'24, Cash and equivalents: $5.6BQ2'24Q3'24, Cash and equivalents: $5.7BQ3'24Q4'24, Cash and equivalents: $5.8BQ4'24, Long-term debt: $4.5BQ4'24Q1'25, Cash and equivalents: $6.1BQ1'25Q2'25, Cash and equivalents: $5.7BQ2'25Q3'25, Cash and equivalents: $5.5BQ3'25Q4'25, Cash and equivalents: $6.4BQ4'25, Long-term debt: $3.7BQ4'25Q1'26, Cash and equivalents: $6.7BQ1'26Q2'26, Cash and equivalents: $6.2BQ2'26Q3'26, Cash and equivalents: $4.8BQ3'26Q4'26, Cash and equivalents: $5.6BQ4'26, Long-term debt: $3.7BQ4'26Q1'27, Cash and equivalents: $7.4BQ1'27$0$2B$4B$6B$8BQ2'23, Cash and equivalents: $4.5BQ3'23, Cash and equivalents: $5.3BQ3'23Q4'23, Cash and equivalents: $5.3BQ4'23, Long-term debt: $5.0BQ1'24, Cash and equivalents: $5.1BQ1'24Q2'24, Cash and equivalents: $5.6BQ3'24, Cash and equivalents: $5.7BQ3'24Q4'24, Cash and equivalents: $5.8BQ4'24, Long-term debt: $4.5BQ1'25, Cash and equivalents: $6.1BQ1'25Q2'25, Cash and equivalents: $5.7BQ3'25, Cash and equivalents: $5.5BQ3'25Q4'25, Cash and equivalents: $6.4BQ4'25, Long-term debt: $3.7BQ1'26, Cash and equivalents: $6.7BQ1'26Q2'26, Cash and equivalents: $6.2BQ3'26, Cash and equivalents: $4.8BQ3'26Q4'26, Cash and equivalents: $5.6BQ4'26, Long-term debt: $3.7BQ1'27, Cash and equivalents: $7.4BQ1'27

Positions at each quarter end, as filed; short-term investments are not included.

Income statement

Last eight quarters, newest first, through Q1 FY2027 filed October 22, 2026.

Lam Research income statement, quarterly
Millions of dollarsQ1 FY2027ended Sep 27, 2026filed Oct 22, 2026Q4 FY2026ended Jun 28, 2026filed Aug 7, 2026Q3 FY2026ended Mar 29, 2026filed Apr 23, 2026Q2 FY2026ended Dec 28, 2025filed Jan 29, 2026Q1 FY2026ended Sep 28, 2025filed Oct 24, 2025Q4 FY2025ended Jun 29, 2025filed Aug 11, 2025Q3 FY2025ended Mar 30, 2025filed Apr 25, 2025Q2 FY2025ended Dec 29, 2024filed Jan 31, 2025YoYQ1 FY2027vs Q1 FY2026
Revenue8,2196,7225,8415,3455,3245,1714,7204,376+54.4%
Cost of revenue—————2,5822,4062,303—
Gross profit4,2993,4792,9112,6512,6852,5902,3142,073+60.1%
Research and development666643583573576580526495+15.6%
Selling, general and administrative349322280268279268226244+24.8%
Operating income3,2842,5132,0471,8101,8291,7411,5621,334+79.5%
Other income (expense)2842(35)263038(25)14−5.3%
Pretax income3,3122,5552,0121,8371,8591,7791,5371,348+78.2%
Income tax55927818624329159206157+92.5%
Net income2,7532,2771,8251,5941,5691,7201,3311,191+75.5%
Diluted EPS ($)2.19—1.451.261.24—1.030.92+76.6%
Diluted shares (millions)1,256—1,2571,2621,269—1,2881,291—

Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.

Balance sheet

Last eight quarters, newest first, through Q1 FY2027 filed October 22, 2026.

Lam Research balance sheet, quarterly
Millions of dollarsQ1 FY2027ended Sep 27, 2026filed Oct 22, 2026Q4 FY2026ended Jun 28, 2026filed Aug 7, 2026Q3 FY2026ended Mar 29, 2026filed Apr 23, 2026Q2 FY2026ended Dec 28, 2025filed Jan 29, 2026Q1 FY2026ended Sep 28, 2025filed Oct 24, 2025Q4 FY2025ended Jun 29, 2025filed Aug 11, 2025Q3 FY2025ended Mar 30, 2025filed Apr 25, 2025Q2 FY2025ended Dec 29, 2024filed Jan 31, 2025YoYQ1 FY2027vs Q1 FY2026
Cash and equivalents7,4375,5794,7516,1806,6936,3915,4515,665+11.1%
Short-term investments—————————
Total current assets18,12415,61113,29714,01814,80714,51713,46013,613+22.4%
Total assets26,35323,53020,79221,39121,90021,34519,96819,840+20.3%
Total current liabilities7,3125,9375,2426,2136,7086,5685,4905,350+9.0%
Long-term debt—3,722———3,720———
Total liabilities12,44511,05910,20711,24611,70711,48410,45711,032+6.3%
Stockholders’ equity13,90812,47110,58510,14510,1939,8629,5118,808+36.5%
Shares outstanding (millions)1,2491,2511,2511,2491,2561,2661,2791,284—

Positions at each period end. Nothing on this statement is derived. Long-term debt is the filed noncurrent line only; no total-debt composite is constructed across filers. Italic figures are derived.

Cash flow statement

Last eight quarters, newest first, through Q1 FY2027 filed October 22, 2026.

Lam Research cash flow statement, quarterly
Millions of dollarsQ1 FY2027ended Sep 27, 2026filed Oct 22, 2026Q4 FY2026ended Jun 28, 2026filed Aug 7, 2026Q3 FY2026ended Mar 29, 2026filed Apr 23, 2026Q2 FY2026ended Dec 28, 2025filed Jan 29, 2026Q1 FY2026ended Sep 28, 2025filed Oct 24, 2025Q4 FY2025ended Jun 29, 2025filed Aug 11, 2025Q3 FY2025ended Mar 30, 2025filed Apr 25, 2025Q2 FY2025ended Dec 29, 2024filed Jan 31, 2025YoYQ1 FY2027vs Q1 FY2026
Operating cash flow3,4981,4571,1411,4801,7792,5541,309742+96.6%
Capital expenditures258189332261185172288188+39.2%
Free cash flow (CFO − capex)3,2401,2688101,2191,5942,3821,021554+103.3%
Depreciation and amortization122120116104102989796+20.1%
Share repurchases1,0252471,1631,4669761,292435698+5.0%
Dividends paid325325326328292295296298+11.4%

10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.

Annual statements

Every fiscal year filed, newest first, through FY2026 filed August 7, 2026.

Income statement

Lam Research income statement, annual
Millions of dollarsFY2026ended Jun 28, 2026filed Aug 7, 2026FY2025ended Jun 29, 2025filed Aug 11, 2025FY2024ended Jun 30, 2024filed Aug 29, 2024FY2023ended Jun 25, 2023filed Aug 15, 2023FY2022ended Jun 26, 2022filed Aug 24, 2022FY2021ended Jun 27, 2021filed Aug 17, 2021FY2020ended Jun 28, 2020filed Aug 18, 2020FY2019ended Jun 30, 2019filed Aug 20, 2019FY2018ended Jun 24, 2018filed Aug 14, 2018FY2017ended Jun 25, 2017filed Aug 15, 2017FY2016ended Jun 26, 2016filed Aug 17, 2016FY2015ended Jun 28, 2015filed Aug 13, 2015FY2014ended Jun 29, 2014filed Aug 26, 2014FY2013ended Jun 30, 2013filed Aug 27, 2013FY2012ended Jun 24, 2012filed Aug 22, 2012FY2011ended Jun 26, 2011filed Aug 19, 2011FY2010ended Jun 27, 2010filed Nov 3, 2010FY2009ended Jun 28, 2009filed Nov 3, 2010
Revenue23,23318,43614,90517,42917,22714,62610,0459,65411,0778,0145,8865,2594,6073,5992,6653,2382,1341,116
Cost of revenue11,5079,4577,8539,6529,3557,8215,4365,2955,9124,4103,2672,9752,6002,1961,5811,7401,164727
Gross profit11,7258,9797,0537,7777,8726,8054,6094,3585,1653,6032,6192,2842,0071,4031,0841,497970389
Research and development2,3762,0961,9021,7271,6041,4931,2521,1911,1901,034914825716684445373321288
Selling, general and administrative1,150982868833886830682702762667631592613601402308241233
Operating income8,2005,9014,2645,1755,3824,4822,6742,4653,2131,9021,074788678118238804425(281)
Other income (expense)635796(66)(189)(111)(99)(18)(62)(90)(114)(47)(37)(51)(33)(3)518
Pretax income8,2625,9584,3605,1095,1934,3712,5752,4473,1521,81296074172367204801430(263)
Income tax997600532598588462323255771114468591(47)36778339
Net income7,2655,3583,8284,5114,6053,9082,2522,1912,3811,698914656632114169724347(302)
Diluted EPS ($)5.764.152.903.323.27*2.69*1.51*1.37*1.32*0.92*0.52*0.37*0.36*0.07*0.14*0.58*0.27*(0.24)*
Diluted shares (millions)1,2611,2901,3201,3581,406*1,453*1,491*1,599*1,808*1,838*1,752*1,771*1,745*1,734*1,252*1,250*1,281*1,256*

Balance sheet

Lam Research balance sheet, annual
Millions of dollarsFY2026ended Jun 28, 2026filed Aug 7, 2026FY2025ended Jun 29, 2025filed Aug 11, 2025FY2024ended Jun 30, 2024filed Aug 29, 2024FY2023ended Jun 25, 2023filed Aug 15, 2023FY2022ended Jun 26, 2022filed Aug 24, 2022FY2021ended Jun 27, 2021filed Aug 17, 2021FY2020ended Jun 28, 2020filed Aug 18, 2020FY2019ended Jun 30, 2019filed Aug 20, 2019FY2018ended Jun 24, 2018filed Aug 14, 2018FY2017ended Jun 25, 2017filed Aug 15, 2017FY2016ended Jun 26, 2016filed Aug 17, 2016FY2015ended Jun 28, 2015filed Aug 13, 2015FY2014ended Jun 29, 2014filed Aug 26, 2014FY2013ended Jun 30, 2013filed Aug 27, 2013FY2012ended Jun 24, 2012filed Aug 22, 2012FY2011ended Jun 26, 2011filed Aug 19, 2011FY2010ended Jun 27, 2010filed Nov 3, 2010FY2009ended Jun 28, 2009filed Nov 3, 2010
Cash and equivalents5,5796,3915,8485,3373,5224,4184,9153,6584,5122,3785,0391,5021,4531,1621,5651,492546374
Short-term investments———————————2,5751,6131,3351,298630281—
Total current assets15,61114,51712,88313,22812,28511,65210,8548,5609,1509,1429,2136,2714,7843,7944,4153,2731,757—
Total assets23,53021,34518,74518,78217,19615,89214,55912,00112,49212,12312,2649,3657,9937,2508,0054,0542,487—
Total current liabilities5,9376,5684,3384,1854,5653,5283,1622,3723,1502,9502,4182,6311,5821,4041,427681559—
Long-term debt3,7223,7204,4664,9654,9624,9614,9593,7681,7601,7793,3789948077777497267—
Total liabilities11,05911,48410,20510,57110,9179,8659,3767,2785,7735,1356,1624,0202,7802,5752,6831,584719—
Stockholders’ equity12,4719,8628,5398,2106,2786,0275,1724,6746,6416,8175,8955,1035,0304,4895,1322,4701,7681,453
Shares outstanding (millions)1,2511,2661,299*1,325*1,370*1,420*1,456*1,445*1,576*1,625*1,603*1,582*1,621*1,631*1,823*1,238*——

Cash flow statement

Lam Research cash flow statement, annual
Millions of dollarsFY2026ended Jun 28, 2026filed Aug 7, 2026FY2025ended Jun 29, 2025filed Aug 11, 2025FY2024ended Jun 30, 2024filed Aug 29, 2024FY2023ended Jun 25, 2023filed Aug 15, 2023FY2022ended Jun 26, 2022filed Aug 24, 2022FY2021ended Jun 27, 2021filed Aug 17, 2021FY2020ended Jun 28, 2020filed Aug 18, 2020FY2019ended Jun 30, 2019filed Aug 20, 2019FY2018ended Jun 24, 2018filed Aug 14, 2018FY2017ended Jun 25, 2017filed Aug 15, 2017FY2016ended Jun 26, 2016filed Aug 17, 2016FY2015ended Jun 28, 2015filed Aug 13, 2015FY2014ended Jun 29, 2014filed Aug 26, 2014FY2013ended Jun 30, 2013filed Aug 27, 2013FY2012ended Jun 24, 2012filed Aug 22, 2012FY2011ended Jun 26, 2011filed Aug 19, 2011FY2010ended Jun 27, 2010filed Nov 3, 2010FY2009ended Jun 28, 2009filed Nov 3, 2010
Operating cash flow5,8586,1734,6525,1793,1003,5882,1263,1762,6562,029———720499881351(78)
Capital expenditures9667593975025463492033032731571751981461611071273644
Free cash flow (CFO − capex)4,8915,4144,2564,6772,5543,2391,9232,8732,3821,872———559392754315(122)
Depreciation and amortization442386360342334307269309326307291278292304101757172
Share repurchases3,8513,4222,8432,0173,8662,6981,3703,7812,6538121585732459567732119331
Dividends paid1,2711,1501,0199088157276576783082431901160—————

Insider activity

Form 4 filings by officers, directors and 10% owners, November 1, 2024 to November 1, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.

Bought, three months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, three months
$48M
8 sales by 4 insiders; officers and directors $48M
Bought, twelve months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, twelve months
$176M
67 sales by 8 insiders; officers and directors $176M

The last 25 transactions

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Oct 23, 2026Archer TimothyPresident and CEOoption exercise31,400$30.03$943K1MOct 26, 2026
Oct 23, 2026Archer TimothyPresident and CEOopen-market sale10b5-131,400$227.02$7M1MOct 26, 2026
Sep 9, 2026Archer TimothyPresident and CEOoption exercise30,000$30.03$901K1MSep 10, 2026
Sep 9, 2026Archer TimothyPresident and CEOopen-market sale10b5-130,000$319.26$10M1MSep 10, 2026
Sep 9, 2026Mayer BethanyDirectoropen-market saleindirect9,557$314.74$3M20,995Sep 10, 2026
Sep 2, 2026Varadarajan SeshasayeeSenior Vice Presidentopen-market sale10b5-120,000$291.32$6M205,546Sep 3, 2026
Sep 2, 2026Varadarajan SeshasayeeSenior Vice Presidentoption exercise12,270$59.88$735K217,816Sep 3, 2026
Sep 2, 2026Varadarajan SeshasayeeSenior Vice Presidentopen-market sale10b5-112,270$291.32$4M205,546Sep 3, 2026
Sep 2, 2026Varadarajan SeshasayeeSenior Vice Presidentoption exercise27,480$30.03$825K233,026Sep 3, 2026
Sep 2, 2026Varadarajan SeshasayeeSenior Vice Presidentopen-market sale10b5-127,480$291.32$8M205,546Sep 3, 2026
Aug 31, 2026Harter AvaChief Legal Officeropen-market sale10b5-15,000$302.46$2M42,462Sep 1, 2026
Aug 6, 2026Archer TimothyPresident and CEOoption exercise30,000$30.03$901K1MAug 7, 2026
Aug 6, 2026Archer TimothyPresident and CEOopen-market sale10b5-130,000$300.00$9M1MAug 7, 2026
Aug 5, 2026Harter AvaChief Legal Officertax withholding5,790$307.42$2M47,462Aug 6, 2026
Jul 13, 2026Talwalkar Abhijit YDirectoropen-market sale10b5-118,282$335.00$6M87,142Jul 14, 2026
Jul 2, 2026Archer TimothyPresident and CEOoption exercise30,000$30.03$901K1MJul 6, 2026
Jul 2, 2026Archer TimothyPresident and CEOopen-market sale10b5-130,000$390.01$12M1MJul 6, 2026
Jun 12, 2026Brandt EricDirectoropen-market sale10b5-1300$355.71$107K198,905Jun 15, 2026
Jun 12, 2026Brandt EricDirectoropen-market sale10b5-11,393$357.24$498K197,512Jun 15, 2026
Jun 12, 2026Brandt EricDirectoropen-market sale10b5-11,100$357.98$394K196,412Jun 15, 2026
Jun 12, 2026Brandt EricDirectoropen-market sale10b5-13,828$359.08$1M192,584Jun 15, 2026
Jun 12, 2026Brandt EricDirectoropen-market sale10b5-11,906$360.15$686K190,678Jun 15, 2026
Jun 12, 2026Brandt EricDirectoropen-market sale10b5-1819$361.21$296K189,859Jun 15, 2026
Jun 12, 2026Brandt EricDirectoropen-market sale10b5-12,708$362.40$981K187,151Jun 15, 2026
Jun 12, 2026Brandt EricDirectoropen-market sale10b5-12,345$363.33$852K184,806Jun 15, 2026

Full insider history for Lam Research, or insider activity across all companies. A record of filings, not a recommendation.

Tracked funds holding it

4 of the tracked managers held LRCX in their latest 13F filing, through August 14, 2026. Weight is the share of the fund’s reported portfolio. How the funds have traded LRCX by quarter.

FundManagerQuarterValueSharesWeightMove
Appaloosa ManagementDavid TepperQ2 2026$166M382,5002.15%held
Altimeter CapitalBrad GerstnerQ2 2026$171M394,0801.74%new
Duquesne Family OfficeStanley DruckenmillerQ2 2026$19M43,6000.36%new
Baron Capital GroupRon BaronQ2 2026$56M129,3180.08%added +10.8%

Sources

Fiscal year ends in month 6; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.

Filer
LAM RESEARCH CORPORATION, CIK 707549 on EDGAR
Extract generated
October 23, 2026
Withheld
1 line-years whose four quarters do not sum to the filed year: buybacks FY2013
Repaired
none
XBRL concepts behind each line

Income statement

Revenue: RevenueFromContractWithCustomerExcludingAssessedTax, Revenues, SalesRevenueNet
Cost of revenue: CostOfGoodsAndServicesSold, CostOfRevenue
Gross profit: GrossProfit
Research and development: ResearchAndDevelopmentExpense
Selling, general and administrative: SellingGeneralAndAdministrativeExpense
Operating income: OperatingIncomeLoss
Other income (expense): NonoperatingIncomeExpense, OtherNonoperatingIncomeExpense
Pretax income: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest, IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Income tax: IncomeTaxExpenseBenefit
Net income: NetIncomeLoss
Diluted EPS ($): EarningsPerShareDiluted
Diluted shares (millions): WeightedAverageNumberOfDilutedSharesOutstanding

Balance sheet

Cash and equivalents: CashAndCashEquivalentsAtCarryingValue
Short-term investments: ShortTermInvestments
Total current assets: AssetsCurrent
Total assets: Assets
Total current liabilities: LiabilitiesCurrent
Long-term debt: LongTermDebt, LongTermDebtNoncurrent
Total liabilities: Liabilities
Stockholders’ equity: StockholdersEquity
Shares outstanding (millions): dei:EntityCommonStockSharesOutstanding

Cash flow statement

Operating cash flow: NetCashProvidedByUsedInOperatingActivities
Capital expenditures: PaymentsToAcquireProductiveAssets
Free cash flow (CFO − capex): not filed
Depreciation and amortization: DepreciationAndAmortization
Share repurchases: PaymentsForRepurchaseOfCommonStock
Dividends paid: PaymentsOfDividends

The data

The statements on this page as files, generated October 23, 2026.

JSON file
/data/financials/LRCX.json